GRAPEVINE, TX — Risk stratification of patients with chronic heart failure and a defibrillating cardiac resynchronization therapy (CRT-D) device may be improved by combining natriuretic peptide levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback